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Professor Rothenberg’s Scholarship
takes a Dramatic Turn
Dr. Hardy: So I need to share the seriousness of the finding [of a genetic
predisposition to Long QT syndrome that may cause arrhythmia and
sudden cardiac arrest] with Sam and tell her we very strongly recommend
that competitive athletics be forsaken.
Mom: Oh no, you can’t tell her anything is wrong. Remember you just
said doctors don’t tell kids Sam’s age. And anyway, remember you told
me these tests aren’t certain!
Dr. Hardy: You are correct that for kids we typically do not report most
disease susceptibility that may affect them later in life. This however has
immediate implications. There is the potential for sudden death without
treatment and an excellent outcome with treatment – including taking
a medication to protect the heart. We’ve already confirmed this result
in a CLIA lab. Because of the severe ramifications for some kids – and
we don’t know who – I must inform her so she’ll give up competitive
swimming.
Mom: No . . . that would devastate her . . . let’s wait till high school
then I can just say I have to go to work earlier so can’t’ take her to 6 am
swim practice.
Dr. Hardy: She should be closely followed by a cardiologist, who may
also consider beta blockers or an implantable defibrillator. We really
need to bring Sam into this discussion now . . .
This difficult conversation is from the play “It’s So Complicated” coauthored by Law & Health Care Program Professor Karen Rothenberg
and Columbia University Medical Center faculty member Dr. Lynn Bush.
The play is included in their new book The Drama of DNA: Narrative
Genomics. The scene depicts a situation in which whole genome
sequencing (a genetic laboratory process that determines the complete
DNA sequence of a person's genome at a single time) revealed genetic
information that was unrelated to the reason the family sought genetic
testing in the first place. Given the rapid growth in our understanding of
the human genome and the decreased costs of whole genome sequencing,
patients and researchers will have to have these difficult conversations
about “incidental findings” and other complex concerns much more
frequently.
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Finding ways to confront and address these concerns has always been
at the heart of Rothenberg’s scholarship, but using drama to do so has
been Rothenberg’s consuming passion for the last five years. Rothenberg
and Bush's new book brings together their collaborative work on the
use of dramatic narrative to understand and facilitate conversations
about genomics. The book uses excerpts from Rothenberg and
Bush’s original plays as well as plays by other authors to examine the
implications of genomic technologies in today’s society and to foster a
greater understanding of how genomic information should be evaluated,
processed, and shared. In his foreword to the book, Dr. Eric Green,
Director of the National Human Genome
Research Institute (NHGRI), comments
that this “novel approach successfully
generates a constructive dialogue about
the ethical, psychological, and societal
challenges that develop with the infusion
of genomics into real-world situations.”
The book, which links readers to online
versions of the plays, promises to be
an invaluable resource to health care
providers and researchers and ultimately
to patients. As Dr. Green notes in his
introduction, a great deal of interest has
already been expressed by members of
the scientific community in early versions
of the plays in the book.
The Drama of DNA is the culmination
Professor Karen Rothenberg's
new book: The Drama of DNA
of Rothenberg’s long-time work studying
the social implications of genetic
research and her personal love of theatre. After serving as the Dean of
UM Carey Law for 10 years, Rothenberg spent academic year 20092010 on sabbatical to focus on theatre as a structured and stimulating
avenue to engage students and the public in identifying and discussing
complex health and science policy issues. She spent her sabbatical year
as a Visiting Professor at the Berman Institute for Bioethics at the Johns
Hopkins University, Scholar-in-Residence at Columbia Law School, and
Senior Sabbatical Fellow at Colombia University Law School’s Center
for the Study of Law and Culture. She also began her collaboration with
Dr. Lynn Bush, Ph.D., M.S., M.A., who shares Rothenberg’s interest in
exploring the use of plays and musicals as a way to encourage dialogue
on complex health and science issues and to identify issues of concern
that should be taken into consideration by health policy makers.
In spring 2010, Professor Rothenberg was asked to give the Robert L.
Levine Lecture at Fordham University School of Law. The talk, which
formed the basis for the article “From Eugenics to the ‘New’ Genetics:
The Play's The Thing,” published in the Fordham Law Review, focused
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on the way theatre engages viewers in a dialogue about
the society they live in. The talk and the subsequent
article examined the relationship between public
opinion and social policy to explore connections and
parallels between the eugenics studies of yesteryear
and modern genetic science, especially with respect
to the role of women and their accountability to future
generations through their reproductive choices. This
article provided a historic perspective on how science
has been portrayed in theatre which led Rothenberg
to consider whether, and how, plays can be used as a
vehicle to engage stakeholders in the present.
Returning to the law school in 2010-11, Rothenberg
continued her focus on how best to bring to life the
ethical and societal issues raised by emerging genomic
technologies. She created an innovative course together
with National Institutes of Health (NIH) bioethicist
Ben Berkman called the “Health and Science Policy
Workshop: The Regulation of Genomic Research” in
which Maryland law students studied the cutting edge
bioethical issues raised by whole genome sequencing
and presented their findings to a group of NIH
researchers, including NHGRI Director Eric Green (see
Law and Health Care Newsletter, Fall 2011).

Selected Works on Genetics and Genomics
by Professor Rothenberg
•

The Drama of DNA: Narrative Genomics, (with
L.W. Bush) Oxford Univ. Press (2014)

•

“Finding Fault? Exploring Legal Duties to
Return Incidental Findings in Genomics
Research,” (with E.R. Pike and B.E. Berkman),
102 Georgetown L.J. 795 (2014)

•

“Setting the Stage: Enhancing Understanding
of Bioethical Challenges with Theatre,” 11 Ind.
Health L. Rev. 1 (2014)

•

“Manipulating Fate: Medical Innovations,
Ethical Implications, Theatrical Illuminations,”
13 Houston Journal of Health Law & Policy 1
(2012)

•

“Teaching Students to be Policymakers: The
Health and Science Policy Workshop on
Genomic Research,” in “Teaching Health Law,”
J Law Med Ethics, (with B. Berkman) 2012
Spring;40(1):147-53

•

“Dialogues, dilemmas, and disclosures: genomic
research and incidental findings,”(with L.W.
Bush) Genet Med, 14(3):293-5 (2012)

In the meantime, Professors Rothenberg and Bush
continued their long distance collaboration and co• “Genes and plays: bringing ELSI issues to life.”
authored two short plays to help convey the complexity
(with L.W. Bush) Genet Med, 14(2):274-7
of ethical issues raised by genomic research that
(2012)
were presented at the 2011 Ethical, Legal, and Social
Implications (ELSI) Congress sponsored by NHGRI.
• “From Eugenics to the ‘New Genetics’: The
The first play, “It's Not That Simple,” focused on
Play’s the Thing,” 79 Fordham Law Review 407
(2010)
whole genome sequencing and the informed consent
process in the context of personal and professional
relationships. The second play, “It's So Complicated!”
highlighted dilemmas involved with returning research results and incidental findings to study participants in
the course of whole genome sequencing. The first play was published in the February 2012 issue of Genetics
in Medicine along with a corresponding article on the theory and process of developing the play, followed
by the second play and accompanying commentary in the March 2012 issue of the same journal. These two
plays and several others they have co-authored have been welcomed by professionals who work in the area of
genomics, including bioethicists, doctors, researchers, and NIH staff. The plays are designed to be acted out
by these professionals and students who take roles in the play that are different from what they do in “real life.”
Rothenberg believes this is critical in order for people to “hear the other voice” on a particular issue. The plays
have been performed by interdisciplinary groups of professionals in Australia, the Netherlands, and London
and at the annual meetings of the American Society of Human Genetics, the American Society for Bioethics
and Humanities, and several institutes within NIH. Recently Rothenberg engaged the staff of the Presidential
Commission for the Study of Bioethical Issues in reading one of the plays aloud.
Following Rothenberg’s return to the law school, she was asked to join NHGRI to study innovative ways
Cont. on page 4
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to engage professionals and the public in the very
complex – and potentially unsettling – work of
genomic research. This is not the first time Professor
Rothenberg has worked with NIH. During sabbaticals
and leaves from the UM Carey School of Law, she
worked in the NIH Office of Research on Women's
Health and the National Institute for Child Health
and Human Development. She now serves as Senior
Advisor on Genomics and Society to the Director
of NHGRI, and as a visiting scholar at the NIH
Department of Bioethics on leave from the University
Panel Discussion with Playwrights at Smithsonian
of Maryland Francis King Carey School of Law. Her
work at NIH is a logical next step for Rothenberg
who has spent the last two decades focused on the ethical, legal and social implications of genetic testing and
research, including legislative approaches to genetic information in the health insurance and employment
context, the impact of genetic research on racial and ethnic populations and women's health care, and the use of
genetic information in the courtroom. At NIH, one of her goals was to find a common language with which the
many stakeholders in the field of genomics could communicate.
By 2012, Professor Rothenberg’s research and collaboration with Dr. Bush led to a joint article that examined
46 plays — spanning three centuries — to enhance understanding of the ethical and social impact of medical
technology on society. The article, “Manipulating Fate: Medical Innovations, Ethical Implications, Theatrical
Illuminations,” which appeared in the Houston Journal of Health Law & Policy, was divided into six "acts" that
highlighted different ways that theatre has dealt with science – from expressing our fear of science, to justifying
bad science, to tackling complex bioethical issues raised by new science. The plays discussed in the final
section of the article, "Genomes & Unknowns," spotlight how the new genomics revolution intensifies human
hopes and expectations for medical innovations, treatments and cures. The plays featured in the article explore
such ethical dilemmas as:
•

Who should or can control the fate of future generations through the use of emerging prenatal 			
technology? 		

•

Should there be limits on how cutting edge genomic technologies are used to change the fate of others?

•

How should we decide who gets access to emerging medical technologies?

In February 2013, Professor Rothenberg was recognized for her outstanding contributions to the health
law field by Indiana University School of Law. She was asked to give the McDonald Merrill Ketcham Award
Lecture and facilitate a panel discussion called “Setting the Stage: Enhancing Understanding of Bioethical
Challenges with Theatre,” which led to a 2014 article in the Indiana Health Law Review by the same title. This
discussion, that included faculty members from the Indiana University School of Medicine, the artistic director
of the Indiana Repertory Theater, and a medical historian, was designed to show how theatre can be used to
identify and resolve our ethical challenges in health care.
Recently, Rothenberg had another chance to discuss her work in a setting outside the walls of NIH – at the
Smithsonian. On April 10, Rothenberg moderated a discussion with several contemporary playwrights who
have used theatre to examine the ethical, legal, and social issues that genomics have introduced into our lives,
as well as to stimulate conversations about biomedical research. Playwrights Dorothy Fortenberry (The Good
Egg), Lisa Loomer (Distracted), Cassandra Medley (Relativity), and Anna Ziegler (Photograph 51) discussed
Cont. on page 11
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Network for Public Health Law Eastern Region
directed by Professor Kathleen Hoke
Takes on Problem Gambling
The Network for Public Health Law’s Eastern Region, housed
at the UM Carey School of Law, is working with the University
of Maryland School of Medicine’s Center for Excellence in
Problem Gambling to reduce the negative public health issues
associated with gambling. The Network’s Eastern Region,
which is directed by UM Carey Law Professor Kathleen Hoke,
is providing the Center with legal guidance and policy research,
with a particular emphasis on prevention of underage and
compulsive gambling. The Center is funded by the Maryland
Department of Health and Mental Hygiene (DHMH) and
is supporting the salary of Special Projects Fellow Athena
Cymrot ’11.
Underage gambling is a growing concern in the United States
and the legalization of casinos offering slot machines and table
games in Maryland has brought the issue to the forefront. To
Professor Kathleen Hoke
help the Center respond to legislative proposals on the subject,
the Network drafted a policy brief on underage gambling and the
public health issues it raises, as well as an overview of gambling and gaming laws across the United States. The
policy brief outlined the negative physical, mental, and social consequences of gambling, especially in young
people. The report noted that the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-V) lists "Gambling Disorder" as an addictive disorder that disrupts personal, family, and vocational
pursuits.1 Additionally, problem and pathological gamblers experience other psychological issues, such as
mood disorders and other addictions, as well as interpersonal issues like lying, stealing, and poor work or
school performance.2 Gambling is also linked with an unusually high risk of suicide.3 The report noted that the
prevalence of gambling problems is higher in adolescents than in adults.4 In fact, the prevalence of gambling
problems in youth may be up to three times the prevalence in adults5 with an estimated 4 to 8% of adolescents
suffering a serious gambling problem and another 10 to 15% of youth at-risk of developing a gambling
problem.6
The field of youth gambling prevention is relatively new and very little has been done in terms of studying
and preventing the problem. As a result, not much is known about the efficacy of programs and policies to
prevent problem gambling in youth.7 This gap in scholarship is where the Center for Excellence in Problem

Cont. on page 11

1 The Diagnostic And Statistical Manual Of Mental Disorders, § 312.31(Am. Psychiatric Ass’n 5th ed.) (2013).
2 J. Nick Badgerow, Apocalypse at Law: The Four Horsemen of the Modern Bar - Drugs, Alcohol, Gambling, and Depression, 77-FEB J. KAN. B.A.
19, 22; Judy Herriff, Gambling: The Hidden Addiction, 88-MAY MICH. B.J. 54, 54.
3 Sanju George & Vijaya Murali, Pathological Gambling: An Overview of Assessment and Treatment, 11 ADVANCES IN PSYCHIATRIC TREATMENT 450, 451 (2005).
4 Carmen Messerlian et al., Youth Gambling Problems: A Public Health Perspective, 20 HEALTH PROMOTION INT’L 69, 70 (2005).
5 Jeffrey Derevensky et al., Adolescent Problem Gambling: Legislative and Policy Decisions, 8 GAMING L. R. 107, 108 (2004). Jeffrey Derevensky
et al.
6 Judy Herriff, Gambling: The Hidden Addiction, 88-MAY MICH. B.J. 54, 54.
7 Prevention Efforts Toward Reducing Gambling Problems; Jeffrey Derevensky, Rina Gupta, Laurie Dickson, Anne-Elyse Deguire (213); Jeffrey
Derevensky & Rina Gupta, Adolescents with Gambling Problems: A Synopsis of Our Current Knowledge, ELEC. J. OF GAMBLING ISSUES, 9
(2004), available at http://youthgambling.mcgill.ca/en/PDF/Publications/2004/ejgi-issue10.pdf.
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Rome Lecture and Roundtable Organized
By Professor Amanda Pustilnik Focus on
Neuroimaging and the Law
On April 24 and 25, the Law & Health Care Program (L&HCP)
held two events focusing on neuroimaging and the law. Both were
the result of efforts by L&HCP Professor Amanda Pustilnik, a
national expert on legal issues presented by neuroscientific work on
memory and pain. The first event was the L&HCP’s annual Rome
Lecture which was given this year by Stanford Law Professor
Hank Greely on the topic of “Neuroimaging, Mindreading, and
the Courts.” The annual Rome Lecture is presented each year by
a scholar renowned in health law and policy. Professor Greely is
the Director of the Center for Law and the Biosciences at Stanford
School of Law and Director of the Stanford Interdisciplinary Group
on Neuroscience and Society. Professor Greely’s Rome Lecture is
available at https://www.youtube.com/watch?v=s7PwDahionk.
Professor Greely’s talk was a kick off to the interdisciplinary
roundtable that took place the following day on the topic of
“Imaging Brains, Changing Minds: Chronic Pain Neuroimaging
and the Law.” The roundtable was designed to create a dialogue
between the fields of law and neuroscience and to make legal
actors aware of recent breakthrough work in neuroimaging that
Rome Lecturer
Professor Hank Greely
has led to a paradigm shift in understanding chronic pain. This
new science has the potential to change legal doctrines and shift
legal and cultural norms about chronic pain diseases and their sufferers. Professor Pustilnik organized and
moderated the roundtable in collaboration with Dr. David Seminowicz from the Department of Neural and Pain
Sciences at the University of Maryland School of Dentistry, and with the support of the American Association
for the Advancement of Science’s Human Rights and Law program. Prominent legal academics, scientists and
judges attended the roundtable which will result in, among other outcomes, a symposium issue of the L&HCP’s
Journal of Health Care Law & Policy next year.
The roundtable was divided into four panel sessions that focused on different
topics relating to the overall theme of the roundtable. Speakers in the first panel,
including Hank Greeley, Dr. Karen Davis who heads the Division of Brain,
Imaging and Behaviour-Systems Neuroscience at Toronto Western Hospital,
and Judge Andre Davis of the U.S. Court of Appeals for the Fourth Circuit,
introduced legal actors to the neuroimaging-based breakthroughs in chronic pain
science and described the primary legal areas where chronic pain is at issue. The
panel also discussed the differences between the models of chronic pain in pain
science versus in law and how chronic pain neuroimaging could affect three legal
domains: legal doctrine, judicial interpretation, and courtroom practice.

Professor Amanda Pustilnik

The second panel focused on the ways in which disability law struggles with
claims of “excess pain” – where the claimant alleges more pain than would be
expected for the injury or disease. Roundtable participants and the panelists, who
included Professor Adam Kolber of Brooklyn Law School, Judge Morris Hoffman
of the Denver District Court, Joel D. Greenspan who chairs of the Department of
Neural and Pain Sciences at the University of Maryland School of Dentistry, and
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Professor Michael Pardo of University of Alabama,
discussed how neuroscience can help us make sense
of individual variability in pain and how policymakers
and legal actors can exercise judgment about whether a
claimant is credible.
The third panel focused on links between emotion
and chronic pain and the legal consequences of
considering chronic pain as “physical” or “emotional”.
Panelists Professor Robert Dinerstein of American
University, Dr. Jennifer A. Haythornthwaite of the
Department of Psychiatry and Behavioral Sciences
at Johns Hopkins University School of Medicine,
Professor Pustilnik and Participants
Professor Jennifer Chandler of University of Ottawa
at Neuroscience Roundtable
Law School, and Dr. Tor D. Wager of the Department
of Psychology and Neuroscience at University
of Colorado, discussed the current scientific and clinical importance of distinctions between organic and
psychogenic pain and when legal doctrines do – and when they should – distinguish between these pain
etiologies.
The final panel addressed the use of scientific evidence to make a legal case or reach a legal decision.
The panel members, Judge Nancy Gertner (ret.) of the U.S. District Court for the District of Massachusetts,
Professor Stacey Tovino of the University of Nevada’s Boyd School of Law, and Dr. Martha J. Farah who
directs the Center for Neuroscience and Society at the University of Pennsylvania, explored why attorneys and
adjudicators may want to use neuroimaging as evidence of chronic pain in court but why neuroimaging can be
reliable in aggregate to educate legal actors, i.e. judges, juries and policy makers, about brain conditions but not
(or not currently) as reliable proof of individual conditions.

Professor Amanda Pustilnik is an Associate Professor of Law at the University of Maryland School of Law,
where she teaches Criminal Law, Evidence, and Law & Neuroscience. Prior to joining the University of
Maryland, she was a Climenko fellow and lecturer on law at Harvard Law School. Before entering the legal
academy, she practiced litigation with Covington & Burling and with Sullivan & Cromwell, where she focused
on white collar criminal matters. Professor Pustilnik also clerked for the Hon. Jose A. Cabranes on the United
States Court of Appeals for the Second Circuit. She graduated Yale Law School and Harvard College, and
has been a visiting scholar at the University of Cambridge, Emmanuel College, in the History and Philosophy
of Science department. Professor Pustilnik has also worked at McKinsey & Company as a management
consultant and is a member of the board of directors of the John Harvard Scholarships.
More information about the roundtable and complete bios of the participants are available at the roundtable
website: https://www.law.umaryland.edu/faculty/conferences/detail.html?conf=166.
The roundtable was generously supported by a gift from Alan & Nancy Eason, as well as proceeds from the
Reuben Shiling Mental Health Law Fund, the Leonard C. Homer/Ober|Kaler Law and Health Care Fund, and
the Dr. Richard H. Heller Fund.
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Law & Health Care Program Honors Adjunct
Professors Sanford Teplitzky and Kevin McAnaney
Next year will be the first time in over a decade that the Law & Health Care
Program (L&HCP)’s Fraud and Abuse Seminar will not be taught by the
adjunct teaching duo of Sanford (Sandy) Teplitzky and Kevin McAnaney. The
two beloved professors have taught the seminar nine times, starting in 2002.
In addition to bringing the complex issues of fraud and abuse to life in the
classroom, Teplitzky and McAnaney have mentored students through health
law competitions, externships and the process of entering the job market.
They are well known for their mastery of the subject matter and their great
humor in the classroom. Although the seminar will be taught by well-qualified
replacements who are certain to gain a following of their own, L&HCP alums
who have worked with Teplitzky and McAnaney reacted with sadness at the
news of their (well-deserved) break from teaching:
•

“I am very grateful that I had the privilege to be a student in Professors
McAnaney and Teplitzky's class. Their energy and passion for teaching
made every class a pleasure to attend, and the subject of fraud and abuse
that much more interesting to learn. I hope that they will teach again so
that other students may have the opportunity to learn from their insights
and experiences.” – Melanie Dang ’14

•

“Learning the fundamentals of healthcare fraud and abuse from two
professors who helped write, develop, and litigate many of the statutory
and regulatory provisions health lawyers practice with every day was
truly priceless. I continue to use many of the materials, notes, and
outlines I prepared in Professors Teplitzky and McAnaney’s class, and
the paper I wrote during my semester with them was published by ABA’s
Health Lawyer as a runner up in their 2012 competition.” Abe Gitterman
’13, Associate, Arnold & Porter

•

“Professors McAnaney and Teplitzky taught our class the fundamentals
we needed to start our careers as health lawyers. They taught beyond
the law, using their extensive experiences to give us keen insights few
other health law students received. Potential employers trusted that I
was well trained because they knew I had been taught by these esteemed
practitioners.”- Hannah Levinson ’13, Associate, Broad & Cassel

Sanford Teplitzky

Kevin McAnaney

Teplitzky is Principal and Co-Chair of the Health Law Practice Group at the
Baltimore law firm of Ober|Kaler. His clients are primarily large health care companies and delivery networks
for whom he provides advice on a variety of fraud and abuse issues. He is one of the most prominent health
lawyers in the U.S. and is a former president of the American Health Lawyers Association which awarded him
the prestigious David J. Greenburg Award in 2008. Prior to joining Ober|Kaler, Teplitzky served as an attorney
for the Office of the General Counsel of the Department of Health, Education and Welfare, where he provided
legal advice to the Health Care Financing Administration and was the primary author of policies and regulations
relating to the Medicare and Medicaid Anti-Fraud and Abuse Amendments of 1977. About his departure from
the law school, Teplitzky said, “It has been a privilege and an honor to be a part of the faculty at the University
of Maryland School of Law for the last 12 years. There were many people who served as mentors for me (many
years ago) and I am thrilled that I played even a small role in the education of the next generation of
health lawyers.”
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McAnaney is a nationally recognized expert on health care fraud and abuse. His solo practice concentrates
on fraud and abuse matters, including compliance reviews, transactional work, and civil and administrative
litigation. He served as the Chief of the Industry Guidance Branch of the Office of Counsel to the Inspector
General from its creation in 1997 until May, 2003 where he worked closely with the Department of Justice to
develop cases involving the anti-kickback and Stark statutes, including the use of such claims as predicates
for False Claims Act litigation. Prior to joining the federal government, McAnaney was a partner in the
Washington, D.C. law office of Dewey Ballantine where he practiced health care, food and drug, and
environmental law. While there he mentored Diane Hoffmann who went on to become Professor of Law and
Director of the L&HCP at Carey Law. About teaching his last class, McAnaney said “[w]hile I will not miss
the commute from Washington, I will miss the students. They are uniformly bright, knowledgeable, and wellspoken. Given all the doom and gloom being spread about the current practice of law, I hope Sandy and I
conveyed to them how much sheer fun it can be to practice in a field you love.”
Professor Hoffmann, who brought McAnaney and Teplitzky together in 2001, said that “Maryland has been
extremely fortunate to have this dynamic duo teach our fraud and abuse course and to have them as part of our
health law program faculty. Every year the course had a waiting list and Kevin and Sandy were always very
generous in their willingness to accept students into the class from off the list. They have enriched our students
and our Program and they will be sorely missed.”

Health Law Regulatory & Compliance Competition
On February 8, 2014, the Law & Health Care Program (L&HCP) held the 3rd Annual Health Law Regulatory
and Compliance Competition. The Competition
is designed to put students in the shoes of health
law attorneys and regulators who handle complex
regulatory and compliance questions. This year,
twelve teams from around the country participated in
the competition including teams from the law schools
at Loyola University Chicago, Saint Louis University,
Southern Illinois University, Catholic University,
Drexel University, University of Texas, American
University, University of Pennsylvania, Georgia State,
Seton Hall, and Cardozo (and a UM Carey Law team).
This year, the team from Seton Hall gained first place
honors.
During the competition, teams of three students
Professor Frank Pasquale (right) talks to students
analyzed a fact pattern using federal health regulations,
at reception after competition
rules, and agency documents, and presented a legal
and policy solution and/or recommendations to a panel
of regulatory and compliance attorneys. This year’s competition, which was organized by L&HCP Professor
Frank Pasquale, Abe Gitterman (UM Carey ’13 now an associate at Arnold & Porter) and Sean Gugerty (2L),
focused on clinical research in the long term care setting. The competition, which was sponsored by the law
firm of Ober|Kaler, included judges from some of the country’s most prominent health law firms including
Arnold & Porter, Ober|Kaler, Epstein Becker & Green, and Hyman, Phelps & McNamera, as well as the
Department of Health and Human Services Office of the Inspector General, FDA, CMS, and private industry.
More details about the competition and judges is available at this link: https://www.law.umaryland.edu/
regulatorycompetition.
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Professor Hoffmann’s NIH-Funded Probiotics
Project Takes a Dramatic Turn As Well
This month, the National Institutes of Health (NIH)
is holding a symposium to commemorate 10 combined
years of research funded by the NIH Roadmap and the
NIH Common Fund, two grant programs that were created to encourage innovation in biomedical research.
L&HCP Director Diane Hoffmann was funded by the
Common Fund’s Human Microbiome Project in 2010,
along with an interdisciplinary group of researchers
at the University of Maryland Baltimore (UMB), to
examine and make recommendations regarding the
regulation of probiotics. As part of the 10 year commemoration of the NIH Roadmap/Common Funds,
the NIH Office of Strategic Coordination organized a
video competition to encourage creative descriptions
of Roadmap/Common Fund programs to be shared
with the general public. Hoffmann and her UMB coinvestigators submitted a humorous video about their
probiotics project based on the television program Law
& Order: Special Victims Unit. The video depicted a
day in the life of the “Special Claims Unit” that was
investigating an egregious false claim on a package of
a fictitious probiotics called “Probiotic Cure-All.” In
addition to law students, Diana-Lynne Hsu and Bill
Rader, Hoffmann acted in the video with co-investigators Dr. Frank Palumbo (School of Pharmacy), Dr.
Jacques Ravel (Institute of Genome Sciences, School
of Medicine), and Virginia Rowthorn (School of Law).

Opening Screen of NIH Video Contest Submission
by L&HCP

Hoffmann’s video depicts a young man buying a
probiotic formula because of the exaggerated claims
on the package, having an adverse reaction, and subsequently reporting it to a physician who calls in the
Bill Rader ('14), Adjunct Professor Frank Palumbo,
Special Claims Unit to investigate the false claims.
and L&HCP Director Diane Hoffmann
The action then shifts to a court room where the manufacturer of Probiotic Cure-All is being raked over the
coals by an indignant judge who decries the lack of substantiation behind the product’s claims. The video appears at the following YouTube link: https://www.youtube.com/watch?v=Ani0bEORweY.
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Prof. Rothenberg
Cont. from p. 4

why and how they used complex topics rooted in genetics —including issues of identity, the power of genetic
information, and the impact of health decisions on family dynamics—in their work, all discussed in the article
"Manipulating Fate" and the book, The Drama of DNA. The program was designed to complement the National
Museum of Natural History exhibition “Genome: Unlocking Life's Code,” which is co-sponsored by NHGRI
and for which Rothenberg was asked to conduct public outreach. The exhibit opened on June 14, 2013 and will
close on September 1, 2014 to travel throughout North America. On the morning of the event, Rothenberg also
organized an NIH workshop for playwrights and scientists to talk about the process and challenges of writing
about complex scientific issues and the opportunities for enhancing collaborations between the artistic and
scientific communities in the future.
What’s next for Rothenberg? In addition to her work on theatre and genomics, she has continued to study the
legal and ethical ramifications of genetic testing and serve as a resource to policy makers who make decisions
about how best to protect patients and foster responsible and creative science. She recently co-authored a paper
“Finding Fault? Exploring Legal Duties to Return Incidental Findings in Genomics Research,” which goes back
to the scenario that started this article – how to deal with the issue of incidental findings that come up when
the whole genome of an individual is sequenced. As science continues its inevitable march forward, Professor
Rothenberg will have ample opportunity to apply the lessons she has learned through legal study and theatre to
ensure that we meet new science together with a shared approach to what is best for all members of society.
Problem Gambling
Cont. from p. 5

Gambling comes in. Most recently the Network provided legal and policy guidance to the Center in its support
of Maryland House Bill 275 and Senate Bill 481, which would prohibit individuals under the age of 21 from
entering a casino or participating in any casino games, making a violation a civil offense punishable by a fine.
The General Assembly passed the legislation during the 2014 session and Maryland Governor Martin O’Malley
recently signed the bill that will go into effect on October 1, 2014. The Network will produce an informational
brochure for Maryland’s judiciary and local law enforcement officials to explain the new law and its purpose
and to let those officials know about the resources the Center provides for those experiencing gambling
problems.
The Network and Center are now beginning work on the topic of Internet gambling, specifically looking at
whether and how Internet gambling could be regulated to prevent underage and compulsive gambling. Other
projects will be developed in collaboration with the Alcohol and Drug Administration at DHMH and the
Maryland Council on Problem Gambling.
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The Law & Health Care Program mourns the loss of Adjunct Professor Robert T. M. Phillips, who died
April 18th after a long battle with myelofibrosis. He was 62.
Professor Phillips began teaching at UM Carey Law in 1996. He was also an adjunct associate professor
of psychiatry at the University of Maryland School of Medicine, and a lecturer and former assistant clinical
professor of psychiatry at Yale University School of Medicine. This semester, he was co-teaching the Mental
Disability and Criminal Law Seminar at the School of Law.
Professor Phillips was the medical director for Forensic Consultation Associates, Inc., which specializes
in psychiatric consultations in civil and criminal litigation, and counted the U.S. Department of Justice and
the U.S. Secret Service among his regular clients. He was also frequently enlisted by Stephen Bright of the
Southern Center for Human Rights to evaluate the mental status of death row inmates.
Phillips was a distinguished fellow of the American Psychiatric Association, and served as its deputy
medical director from 1993 to 1998. Lawrence Fitch, with whom Phillips co-taught for 19 years, says that
throughout the long and prosperous career that followed that difficult moment, “his moral compass never
deviated” and “his commitment to social justice endured.”
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